Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Norman Wolmark
Based on 40 articles published since 2010
(Why 40 articles?)
||||
Expertise Level
The expertise of Norman Wolmark ranks in the
  • Top 0.43%
  • ... of 274,566 published authors worldwide on Breast Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 40 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Wolmark, Norman   ·   Wolmark, N
Work Locations
Details
Most likely:    National Surgical Adjuvant Breast and Bowel Project      
2019
  • 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom. · 2 Univeristy of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA. · 3 Royal Cornwall Hospitals National Health Service Foundation Trust, Treliske, United Kingdom. · 4 Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool, United Kingdom. · 5 Montreal Jewish General Hospital Segal Cancer Centre, Montreal, Quebec, Canada. · 6 Centre Hospitalier Université de Quebec-Universite Laval, Quebec City, Quebec, Canada. · 7 Centre Hospitalier Université de Montréal, Montreal, Quebec, Canada. · 8 Baylor College of Medicine, Houston, TX. · 9 Queen's University Belfast, Belfast, United Kingdom. · 10 Joe Arrington Cancer Research and Treatment Center, Lubbock, TX. · 11 National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom. · 12 University College London Hospitals National Health Service Foundation Trust, London, United Kingdom. · 13 McGill University Health Centre, Montreal, Quebec, Canada. · 14 The Institute of Cancer Research, London, United Kingdom. · 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA. · 16 Allegheny Health Network Cancer Institute, Pittsburgh, PA. · 17 International Drug Development Institute, Brussels, Belgium. · 18 Independent Cancer Patients Voice, London, United Kingdom. · 19 Pfizer, New York, NY. · 20 Bicycle Therapeutics, Boston, MA. · Pubmed 30523750
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Nova Tower 2, 100 Allegheny Square, Pittsburgh, PA, 15212, USA. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Nova Tower 2, 100 Allegheny Square, Pittsburgh, PA, 15212, USA. · University of Pittsburgh, 4200 Fifth Ave, Pittsburgh, PA, 15260, USA. · Centre Hospitalier de L'Universite ́ de Montréal, 3840 St Urbain St, Montreal, QC, H2W 1T8, Canada. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057, USA. · Massey Cancer Center, Virginia Commonwealth University, 401 College Street, Box 980037, Richmond, VA, 23298, USA. · Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA, 15213, USA. · Orlando Health UF Health Cancer Center, 1400 S Orange Avenue, Orlando, FL, 32876, USA. · Pubmed 31428908
2018
  • Department of Oncology. · Department of Health Sciences Research. · Department of Human Oncology, Allegheny Health Network Cancer Institute. · National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio). · Department of Gynecology and Obstetrics, University Hospital, Frankfurt. · Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital, Erlangen, Germany. · RIKEN Center for Integrative Medical Science, Yokohama, Japan. · Department of Medicine, University of Pittsburgh Cancer Institute. · Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. · Yonsei University College of Medicine, Seoul, South Korea. · Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA. · Pubmed 29768301
  • German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. Electronic address: · Baylor University Medical Center, Dallas, TX, USA. · HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Women & Infants Hospital of Rhode Island, Providence, RI, USA. · University of California San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · AbbVie Inc, North Chicago, IL, USA. · Ulm University, Ulm, Germany. · Brigham and Women's Hospital, Boston, MA, USA. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA. · Texas Oncology, US Oncology, Dallas, TX, USA. · Alicante University General Hospital, ISABIAL, GEICAM (Spanish Breast Cancer Research Group), Alicante, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Magee-Womens Hospital, Pittsburgh, PA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Pubmed 29501363
  • National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · UF Health Cancer Center at Orlando Health, 1400 S., Orange Avenue, MP 700, Orlando, FL, 32806, USA. · NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · Yonsei University College of Medicine, Seoul, South Korea. · Genomic Health, Inc, Redwood City, CA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Pubmed 29128898
2017
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; University of Pittsburgh Cancer Institute School of Medicine, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Virginia Commonwealth University, Massey Cancer Center, Richmond, VA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; UF Health Cancer Center at Orland Health, Orlando, FL, USA. · Pubmed 28285537
  • Joanne L. Blum, Lina Asmar, Nicholas J. Robert, Joyce A. O'Shaughnessy, Svetislava J. Vukelja, Devchand Paul, and Stephen E. Jones, US Oncology Research · Lina Asmar, McKesson Specialty Health, The Woodlands · Joanne L. Blum and Joyce A. O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas · Svetislava J. Vukelja, Texas Oncology-Tyler, Tyler, TX · Patrick J. Flynn, Charles E. Geyer Jr, Samuel A. Jacobs, Judith O. Hopkins, Louis Fehrenbacher, Alan P. Lyss, Adam M. Brufsky, Sandra M. Swain, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project/NRG Oncology · Greg Yothers, Jong-Hyeon Jeong, and Linda H. Colangelo, NRG Oncology · Greg Yothers, John-Hyeon Jeong, and Linda H. Colangelo, The University of Pittsburgh · Samuel A. Jacobs, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine · Adam M. Brufsky, Magee-Womens Hospital at University of Pittsburgh Medical Center · Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh · Henry Leonidas Gómez, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network, Philadelphia, PA · Patrick J. Flynn, Metro-Minnesota Community Oncology Research Consortium, Minneapolis, MN · Charles E. Geyer Jr, Massey Cancer Center, Virginia Commonwealth University, Richmond · Nicholas J. Robert, Virginia Cancer Specialists, Fairfax, VA · Judith O. Hopkins, The Southeastern Medical Oncology Center, Goldsboro, NC · Chau T. Dang, The Alliance, Boston, MA · Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York, NY · Henry Leonidas Gómez, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru · Louis Fehrenbacher, Kaiser Permanente Oncology Clinical Trials Northern California, Vallejo, CA · Alan P. Liss, Heartland Cancer Research National Cancer Institute Community Oncology Research Program at Missouri Baptist Cancer Center, St Louis, MO · Devchand Paul, Rocky Mountain Cancer Centers, Denver, CO · Sandra M. Swain, MedStar Washington Hospital Center Washington Cancer Institute, and Georgetown University Medical Center, Washington, DC · and Eleftherios P. Mamounas, UF Cancer Center at Orlando Health, Orlando, FL. · Pubmed 28398846
  • National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania. · Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania3University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania4Kaiser Permanente, Northern California, Vallejo, California. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania5UF Cancer Center at Orlando Health, Orlando, Florida. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania6Washington Cancer Institute, Medstar Washington Hospital Center, Washington, DC7Georgetown University Medical Center, Washington, DC. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania8Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania9Virginia Commonwealth University, Massey Cancer Center, Richmond. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania2Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania10Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · Pubmed 27812689
  • National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Columbia River Oncology Program, Portland, OR. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Medicine, Oncology, University of Pittsburgh Cancer Institute, and Magee-Womens Hospital Womens Cancer Clinic, Pittsburgh, PA. Electronic address: · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Medicine, Oncology, University of Pittsburgh Cancer Institute, and Magee-Womens Hospital Womens Cancer Clinic, Pittsburgh, PA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Centre hospitalier de l'Université de Montreal (CHUM), Montréal, Québec, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Western Oncology Research Consortium, Portland, OR. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Northern Indiana Cancer Research Consortium, Mishawaka, IN. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Southeast Clinical Oncology Research Consortium, Roper St Francis Cancer Care, Charleston, SC. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Michigan Cancer Research Consortium Community, Ann Arbor, MI. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Dayton, Dayton, OH. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Kalamazoo, and the West Michigan Cancer Center, Kalamazoo, MI. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Kaiser Permanente, San Diego, CA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Oncology, UF Cancer Center at Orlando Health, Orlando, FL. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC; Georgetown University Medical Center, Washington, DC. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA. · Pubmed 27693116
  • Affiliations of authors: National Surgical Adjuvant Breast and Bowel Project (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA (EPM, SP, SRK, TBJ, BCL, DLW, NW) · UF Health Cancer Center at Orland Health, Orlando, FL (EPM) · NRG Oncology, Pittsburgh, PA (QL, GT, JHJ, JPC) · University of Pittsburgh, Pittsburgh, PA (QL, GT, JHJ, JPC) · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea (SP) · Genomic Health, Inc., Redwood City, CA (FLB, SMB, FJ, DBC, APS, SS) · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (TBJ, DLW, NW) · University of Pittsburgh Medical Center, Pittsburgh, PA (BCL). · Pubmed 28122895
  • NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · University of Pittsburgh Cancer Institute School of Medicine, Pittsburgh, PA, USA. · Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA. · Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. · San Juan MBCCOP, San Juan, PR, USA. · University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA, USA. · School of Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, CA, USA. · Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA. · CCOP, Colorado Cancer Research Program, Colorado Springs, CO, USA. · CCOP, North-West Medical Specialties, Tacoma, WA, USA. · Kansas City Clinical Oncology Program, Kansas City, MO, USA. · Jewish General Hospital, McGill University, Montréal, QC, Canada. · Genesys Regional Medical Center, Grand Blanc, MI, USA. · Dayton CCOP, Dayton, OH, USA. · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA. · Georgetown University Medical Center, Washington, DC, USA. · UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · Pubmed 27864694
2016
  • NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; University of California, Los Angeles, CA, USA. Electronic address: · NRG Oncology, Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Surgical Oncology, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; The Jewish General Hospital, McGill University, Montréal, QC, Canada. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southwest Oncology Group, San Antonio, TX, USA; Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Alliance for Clinical Trials in Oncology/American College of Surgeons Oncology Group, Chicago, IL, USA; Nashville Breast Center, Nashville, TN, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southwest Oncology Group, San Antonio, TX, USA; Eastern Cooperative Oncology Group/American College of Radiology Imaging Network, Philadelphia, PA, USA; Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Hematology/Oncology, Magee Womens Hospital/University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Dayton Physicians, Dayton, OH, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Missouri Valley Cancer Consortium, Omaha, NE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southeast Clinical Oncology Research Consortium National Cancer Institute Community Oncology Research Program, Winston Salem, NC, USA; Department of Hematology/Oncology, Forsyth Regional Cancer Center, Winston Salem, NC, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Medical Oncology, Kaiser Permanente, Northern California Vallejo, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Medical Oncology Colorado Cancer Research Program, Denver, CO, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Community Clinical Oncology Program, Christiana Care Health Systems, Wilmington, DE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Atlanta Regional Community Clinical Oncology Program, Atlanta, GA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Pubmed 26686960
  • NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Jewish General Hospital, McGill University, Montreal, QC, Canada. Electronic address: · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Surgical Oncology, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; University of California, Los Angeles, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SWOG, San Antonio, TX, USA; Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; ALLIANCE/ACOSOG, Chicago, IL, USA; Nashville Breast Center, Nashville, TN, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SWOG, San Antonio, TX, USA; ECOG/ACRIN, Philadelphia, PA, USA; Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Hematology/Oncology, Magee Womens Hospital/University of Pittsburgh Department of Hematology/Oncology, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Dayton Physicians LLC, Dayton, OH, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Missouri Valley Cancer Consortium, Omaha, NE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SCOR NCORP, Winston Salem, NC, USA; Department of Hematology/Oncology, Forsyth Regional Cancer Center, Winston Salem, NC, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Medical Oncology, Kaiser Permanente Northern California Vallejo, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Medical Oncology Colorado Cancer Research Program, Denver, CO, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; CCOP, Christiana Care Health Systems, Newark, DE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Atlanta Regional Community Clinical Oncology Program, Atlanta, GA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Pubmed 26686957
  • Norman Wolmark, Eleftherios P. Mamounas, and Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project Operations Center · Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital · Gong Tang, University of Pittsburgh · and Gong Tang, NRG Oncology, Pittsburgh, PA · Eleftherios P. Mamounas, UF Health Cancer Center at Orlando Health, Orlando, FL · Frederick L. Baehner, Steven M. Butler, Farid Jamshidian, Amy P. Sing, and Steven Shak, Genomic Health, Redwood City, and Frederick L. Baehner, University of California, San Francisco, San Francisco CA · and Soonmyung Paik, Yonsei University College of Medicine, Seoul, Korea. · Pubmed 27217450
  • NRG Oncology/ National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA (IJ, EHR, EPM, NW) · Department of Surgery University of Texas Health Science Center, San Antonio, TX (IJ) · NRG Oncology Statistics & Data Management Center, and the Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA (HB, JHJ) · NIH/NCI/Division of Cancer Epidemiology and Genetics, Bethesda, MD (WFA) · Markey Cancer Center, University of Kentucky, Lexington, KY (EHR) · UF Cancer Center at Orlando Health, Orlando, FL (EPM) · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (NW). · Pubmed 26518884
2015
  • National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA, USA. Electronic address: · NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Minority-Based CCOP, San Juan, Puerto Rico. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of Pittsburgh Cancer Institute, Magee Womens Hospital, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of California at Irvine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, Orange, CA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Colorado Cancer Research Program, Colorado Springs, CO, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Northwest Medical Specialties, Tacoma, WA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; CCOP, Kansas City, MO, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Jewish General Hospital, McGill University, Montréal, QC, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Genesys Regional Medical Center, Grand Blanc, MI, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; CCOP, Dayton, Dayton, OH, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Pubmed 26272770
  • Katherine L. Pogue-Geile, Nan Song, Patrick G. Gavin, Seong-Rim Kim, Nicole L. Blackmon, Melanie Finnigan, Priya Rastogi, Louis Fehrenbacher, Eleftherios P. Mamounas, Sandra M. Swain, D. Lawrence Wickerham, Charles E. Geyer Jr, Norman Wolmark, and Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project (now part of NRG Oncology) · Jong-Hyeon Jeong and Joseph P. Costantino, NRG Oncology Statistics and Data Management Center · Jong-Hyeon Jeong and Joseph P. Costantino, Graduate School of Public Health, University of Pittsburgh · Priya Rastogi, University of Pittsburgh Cancer Institute · D. Lawrence Wickerham and Norman Wolmark, Allegheny Cancer Center, Allegheny General Hospital, Pittsburgh, PA · Louis Fehrenbacher, Kaiser-Permanente, Northern California, Vallejo, CA · Eleftherios P. Mamounas, UF Health Cancer Center, Orlando Health, Orlando, FL · Sandra M. Swain, Washington Cancer Institute, Medstar Washington Hospital Center, Washington, DC · Charles E. Geyer Jr, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA · and Soonmyung Paik, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea. · Pubmed 25559813
2014
  • US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: · US Food and Drug Administration, Silver Spring, MD, USA. · HELIOS Klinikum, Berlin, Germany. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA. · Institut Bergonié INSERM U916 and Université Bordeaux Segalen, Bordeaux, France. · Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, UK. · San Raffaele Scientific Institute, Milan, Italy. · Fondazione Michelangelo, Milan, Italy. · Medstar Washington Hospital Center, Washington, DC, USA. · EORTC Headquarters, Brussels, Belgium. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · St Gertrauden Hospital, Berlin, Germany. · MD Anderson Cancer Center Orlando, Orlando, FL, USA. · KarolinskaInstitutet and University Hospital, Stockholm, Sweden. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · University Women's Hospital, Kiel, Germany. · Jules Bordet Institute, Brussels, Belgium. · Frauenklinik des Universitätsklinikums, Erlangen, Germany. · Universitäts Frauenklinik, Rostock, Germany. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Hospital of the Ludwig Maximilian University of Munich, Munich, Germany. · Pubmed 24529560
2013
  • Sandra M. Swain, Gong Tang, Charles E. Geyer Jr, Priya Rastogi, James N. Atkins, Paul P. Donnellan, Louis Fehrenbacher, Catherine A. Azar, André Robidoux, Jonathan A. Polikoff, Adam M. Brufsky, David D. Biggs, Edward A. Levine, John L. Zapas, Louise Provencher, Soonmyung Paik, Joseph P. Costantino, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project (NSABP) · Norman Wolmark, Allegheny General Hospital, Allegheny Health Network · Gong Tang and Joseph P. Costantino, NSABP Biostatistical Center and University of Pittsburgh Graduate School of Public Health · Priya Rastogi, University of Pittsburgh Cancer Institute · Adam M. Brufsky, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA · Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC · Charles E. Geyer Jr, Virginia Commonwealth University, Richmond, VA · James N. Atkins, Southeast Cancer Control Consortium-Community Clinical Oncology Program, Goldsboro · Edward A. Levine, Wake Forest University, Winston-Salem, NC · Paul P. Donnellan, University Hospital, Galway, and the All-Ireland Cooperative Oncology Research Group, Dublin, Ireland · Louis Fehrenbacher, Kaiser Permanente Northern California, Vallejo · Jonathan A. Polikoff, Kaiser Permanente Southern California, San Diego, CA · Catherine A. Azar, Kaiser Permanente, Denver, CO · André Robidoux, Centre hopitalier de l'Université de Montréal (CHUM), Montréal · Louise Provencher, CHU de Québec, Hôpital du Saint-Sacrement, Québec City, QC, Canada · David D. Biggs, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE · John L. Zapas, Medstar Franklin Square Medical Center, Baltimore, MD · Donald W. Northfelt, Mayo Clinic Arizona, Scottsdale, AZ · and Eleftherios P. Mamounas, MD Anderson Cancer Center, Orlando, FL. · Pubmed 23940225
  • Affiliations of authors: National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA (J-HJ, HB, PR, LF, EHR, SMS, EPM, DLW, CEG,Jr, JPC, NW, SP) · Division of Pathology, NSABP (KLP-G, CK, NT, PGG, DF, YT, OLB, AL, S-IK, MLR, MYR, NLB, S-RK, ZDH) · Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA (J-HJ, HB, JPC) · PhenoPath Laboratories, PLLC, Seattle, WA (LCG) · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX (NS) · Department of Pathology, University Medical Center Hamburg-Eppendorf, University Cancer Center, Hamburg, Germany (EB) · Department of Pathology, Catholic University of Korea, Seoul, Republic of South Korea (AL) · University of Pittsburgh Cancer Institute, Pittsburgh, PA (PR) · Department of Oncology, Kaiser Permanente, Northern California, Vallejo, CA (LF) · Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY (EHR) · Department of Medicine, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC (SMS) · Department of Surgery, MD Anderson Cancer Center Orlando, Orlando, FL (EPM) · Department of Medicine, Virginia Commonwealth University, Richmond, VA (CEG, Jr) · Department of Surgery, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (DLW, NW) · Department of Biomedical Science, Severance Biomedical Science Institute, and Department of Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea (SP). · Pubmed 24262440
2015
  • National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA, USA, · Pubmed 25542269
2013
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA. · Pubmed 24202240
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Electronic address: · Pubmed 24095300
Probable:    Miscellaneous institutions in Pittsburgh      
2019
  • NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. · NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. · Centre hospitalier de l'université de Montréal, Montréal, QC, Canada. · Cleveland Clinic, Cleveland, OH, USA. · QuironSalud Group, IOB Institute of Oncology, Madrid, Barcelona, Spain. · Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. · Present address: ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy. · ASST Fatebenefratelli Sacco - PO Fatebenefratelli, Milan, Italy. · Roper St. Francis Healthcare, Charleston, SC, USA. · Azienda Ospedaliera San Gerardo, Monza, Italy. · International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium. · Hospital Universitario, Coruña, Spain. · Fondazione IRCCS Istituto Nazionale di Tumori, Milan, Italy. · Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of South Korea. · Department of Medicine, University of Florida Health, Gainsville, FL, USA. · University of Pittsburgh, Pittsburgh, PA, 15212, USA. · Pubmed 31796073
2018
  • Irene L. Wapnir, Stanford University School of Medicine, Stanford, CA · Karen N. Price and Shari Gelber, Frontier Science and Technology Research Foundation, Richard D. Gelber, Frontier Science and Technology Research Foundation, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, Meredith M. Regan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Stewart J. Anderson, University of Pittsburgh Graduate School of Public Health · Priya Rastogi, University of Pittsburgh Cancer Institute · Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA · André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec · Alexander H.G. Paterson, Tom Baker Cancer Centre, Calgary, Alberta, Canada · Miguel Martín, CIBERONC, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid · José Manuel Baena-Cañada, Hospital Puerta del Mar, Cádiz, Spain · Johan W.R. Nortier, Leids Universitair Medisch Centrum, Leiden, Netherlands · Mothaffar F. Rimawi, Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX · István Láng, National Institute of Oncology, Budapest, Hungary · Beat Thürlimann, Kantonsspital, St. Gallen · Stefan Aebi, Lucerne Cantonal Hospital and University of Bern, Switzerland · Eleftherios P. Mamounas, Orlando Health University of Florida Health Cancer Center, Orlando, FL · Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA · and Alan S. Coates, University of Sydney, Sydney, Australia. · Pubmed 29443653
2017
  • All authors: National Surgical Adjuvant Breast and Bowel Project/NRG Oncology · Reena S. Cecchini, Priya Rastogi, Jong-Hyeon Jeong, and Adam M. Brufsky, University of Pittsburgh · Priya Rastogi and Adam M. Brufsky, Magee-Womens Hospital · Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA · Patricia A. Ganz, University of California at Los Angeles, Los Angeles · Louis Fehrenbacher, Kaiser Permanente, Vallejo · Jonathan Polikoff, Kaiser Permanente, San Marco, CA · Edward H. Romond, University of Kentucky, Lexington, KY · Charles E. Geyer Jr, Virginia Commonwealth University, Richmond, VA · Sandra M. Swain and John L. Zapas, MedStar Washington Hospital Center, Washington, DC · Howard M. Gross, Dayton National Cancer Institute Community Oncology Research Program (NCORP), Dayton, OH · Patrick J. Flynn, Metro-Minnesota Community Clinical Oncology Program (CCOP), Woodbury, MN · Tanya A. Wahl, Fred Hutchinson Cancer Research Center, Seattle, WA · Thomas E. Seay, Atlanta Regional CCOP, Atlanta, GA · James L. Wade III, Heartland NCORP, Decatur, IL · David D. Biggs, Christiana Care Health System, Newark, DE · James N. Atkins, Southeast Clinical Oncology Research Consortium NCORP, Goldsboro, NC · and Eleftherios P. Mamounas, Orlando Health, Orlando, FL. · Pubmed 29072977
  • NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · University of Pittsburgh Cancer Institute School of Medicine, Pittsburgh, PA, USA. · Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA. · Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. · San Juan MBCCOP, San Juan, PR, USA. · University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA, USA. · School of Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, CA, USA. · Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA. · CCOP, Colorado Cancer Research Program, Colorado Springs, CO, USA. · CCOP, North-West Medical Specialties, Tacoma, WA, USA. · Kansas City Clinical Oncology Program, Kansas City, MO, USA. · Jewish General Hospital, McGill University, Montréal, QC, Canada. · Genesys Regional Medical Center, Grand Blanc, MI, USA. · Dayton CCOP, Dayton, OH, USA. · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA. · Georgetown University Medical Center, Washington, DC, USA. · UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · Pubmed 27864694
  • NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA. · NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada. · GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain. · BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands. · NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada. · IBCSG and National Institute of Oncology, Budapest, Hungary. · IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Pubmed 27663567
2015
  • NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center, 12th Flr., Pittsburgh, PA, 15212, USA. · Pubmed 26126970
Probable:    University of Pittsburgh   Contact    
2019
  • NRG Oncology, Pittsburgh, PA, USA; MHP Radiation Oncology Institute, St Joseph Mercy Hospital Campus, Pontiac, MI, USA. Electronic address: · NRG Oncology, Pittsburgh, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology, Pittsburgh, PA, USA; Ohio State University Comprehensive Cancer Center-Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH, USA. · NRG Oncology, Pittsburgh, PA, USA; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · NRG Oncology, Pittsburgh, PA, USA; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · NRG Oncology, Pittsburgh, PA, USA; University of Colorado Cancer Center, Aurora, CO, USA. · NRG Oncology, Pittsburgh, PA, USA; Arizona Breast Cancer Specialists, Arizona Center for Cancer Care, Scottsdale, AZ, USA. · NRG Oncology, Pittsburgh, PA, USA; University of California at Los Angeles, Los Angeles, CA, USA. · Carnegie Mellon University, Pittsburgh, PA, USA. · NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, USA. · NRG Oncology, Pittsburgh, PA, USA; Yonsei University College of Medicine, Seoul, Korea. · NRG Oncology, Pittsburgh, PA, USA; MD Anderson Cancer Center, Houston, TX, USA. · Mayo Clinic Florida, Jacksonville, FL, USA. · Southwest Oncology Group Cancer Research Network, Hope Foundation for Cancer Research, Portland, OR, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. · NRG Oncology, Pittsburgh, PA, USA; Orlando Health, UF Health Cancer Center, Orlando, FL, USA. · NRG Oncology, Pittsburgh, PA, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA. · NRG Oncology, Pittsburgh, PA, USA; Centre Hospitalier Universitaire de Québec-Université Laval, Pavillon Hôtel-Dieu de Québec, Québec City, QC, Canada. · NRG Oncology, Pittsburgh, PA, USA; Community Clinical Oncology Program, William Beaumont Hospital, Sterling Heights, MI, USA. · NRG Oncology, Pittsburgh, PA, USA; Summit Cancer Center, Post Falls, ID, USA. · NRG Oncology, Pittsburgh, PA, USA; Mayo Clinic, Rochester, MN, USA. · NRG Oncology, Pittsburgh, PA, USA; Saint Agnes Hospital, Baltimore, MD, USA; Thomas Jefferson University, Baltimore, MD, USA. · NRG Oncology, Pittsburgh, PA, USA; Winship Cancer Institute of Emory University, Atlanta, GA, USA. · NRG Oncology, Pittsburgh, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · Pubmed 31813636
  • From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany · the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.) · Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.) · the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.) · the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh · Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.) · Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.) · the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.) · the National Cancer Institute, Mexico City (C.A.-S.) · the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California · Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.) · the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.) · Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai · the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.) · F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.) · and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.). · Pubmed 30516102
  • NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. · NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. · Centre hospitalier de l'université de Montréal, Montréal, QC, Canada. · Cleveland Clinic, Cleveland, OH, USA. · QuironSalud Group, IOB Institute of Oncology, Madrid, Barcelona, Spain. · Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. · Present address: ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy. · ASST Fatebenefratelli Sacco - PO Fatebenefratelli, Milan, Italy. · Roper St. Francis Healthcare, Charleston, SC, USA. · Azienda Ospedaliera San Gerardo, Monza, Italy. · International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium. · Hospital Universitario, Coruña, Spain. · Fondazione IRCCS Istituto Nazionale di Tumori, Milan, Italy. · Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of South Korea. · Department of Medicine, University of Florida Health, Gainsville, FL, USA. · University of Pittsburgh, Pittsburgh, PA, 15212, USA. · Pubmed 31796073
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Nova Tower 2, 100 Allegheny Square, Pittsburgh, PA, 15212, USA. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Nova Tower 2, 100 Allegheny Square, Pittsburgh, PA, 15212, USA. · University of Pittsburgh, 4200 Fifth Ave, Pittsburgh, PA, 15260, USA. · Centre Hospitalier de L'Universite ́ de Montréal, 3840 St Urbain St, Montreal, QC, H2W 1T8, Canada. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057, USA. · Massey Cancer Center, Virginia Commonwealth University, 401 College Street, Box 980037, Richmond, VA, 23298, USA. · Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA, 15213, USA. · Orlando Health UF Health Cancer Center, 1400 S Orange Avenue, Orlando, FL, 32876, USA. · Pubmed 31428908
2012
  • NSABP Biostatistical Center, One Sterling Plaza, Pittsburgh, PA 15213, USA. · Pubmed 23060039
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 40 total) written by Norman Wolmark about Breast Neoplasms:

  • Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. 2019
  • Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial. 2019
  • Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. 2019
  • NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2 2019
  • Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial. 2019
  • Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination. 2019
  • Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab. 2018
  • Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. 2018
  • Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. 2018
  • 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology. 2018
Show List of Full Article Records
Google Searches

Learn more about Norman Wolmark using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Surgical Adjuvant Breast and Bowel Project
Miscellaneous institutions in Pittsburgh
University of Pittsburgh
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Surgical Adjuvant Breast and Bowel Project
2019
  • 1 The Royal Marsden National Health Service Foundation Trust, London, United Kingdom. · 2 Univeristy of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA. · 3 Royal Cornwall Hospitals National Health Service Foundation Trust, Treliske, United Kingdom. · 4 Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool, United Kingdom. · 5 Montreal Jewish General Hospital Segal Cancer Centre, Montreal, Quebec, Canada. · 6 Centre Hospitalier Université de Quebec-Universite Laval, Quebec City, Quebec, Canada. · 7 Centre Hospitalier Université de Montréal, Montreal, Quebec, Canada. · 8 Baylor College of Medicine, Houston, TX. · 9 Queen's University Belfast, Belfast, United Kingdom. · 10 Joe Arrington Cancer Research and Treatment Center, Lubbock, TX. · 11 National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom. · 12 University College London Hospitals National Health Service Foundation Trust, London, United Kingdom. · 13 McGill University Health Centre, Montreal, Quebec, Canada. · 14 The Institute of Cancer Research, London, United Kingdom. · 15 National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA. · 16 Allegheny Health Network Cancer Institute, Pittsburgh, PA. · 17 International Drug Development Institute, Brussels, Belgium. · 18 Independent Cancer Patients Voice, London, United Kingdom. · 19 Pfizer, New York, NY. · 20 Bicycle Therapeutics, Boston, MA. · Pubmed 30523750
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Nova Tower 2, 100 Allegheny Square, Pittsburgh, PA, 15212, USA. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Nova Tower 2, 100 Allegheny Square, Pittsburgh, PA, 15212, USA. · University of Pittsburgh, 4200 Fifth Ave, Pittsburgh, PA, 15260, USA. · Centre Hospitalier de L'Universite ́ de Montréal, 3840 St Urbain St, Montreal, QC, H2W 1T8, Canada. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057, USA. · Massey Cancer Center, Virginia Commonwealth University, 401 College Street, Box 980037, Richmond, VA, 23298, USA. · Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA, 15213, USA. · Orlando Health UF Health Cancer Center, 1400 S Orange Avenue, Orlando, FL, 32876, USA. · Pubmed 31428908
2018
  • Department of Oncology. · Department of Health Sciences Research. · Department of Human Oncology, Allegheny Health Network Cancer Institute. · National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio). · Department of Gynecology and Obstetrics, University Hospital, Frankfurt. · Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital, Erlangen, Germany. · RIKEN Center for Integrative Medical Science, Yokohama, Japan. · Department of Medicine, University of Pittsburgh Cancer Institute. · Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. · Yonsei University College of Medicine, Seoul, South Korea. · Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA. · Pubmed 29768301
  • German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. Electronic address: · Baylor University Medical Center, Dallas, TX, USA. · HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Women & Infants Hospital of Rhode Island, Providence, RI, USA. · University of California San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · AbbVie Inc, North Chicago, IL, USA. · Ulm University, Ulm, Germany. · Brigham and Women's Hospital, Boston, MA, USA. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA. · Texas Oncology, US Oncology, Dallas, TX, USA. · Alicante University General Hospital, ISABIAL, GEICAM (Spanish Breast Cancer Research Group), Alicante, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Magee-Womens Hospital, Pittsburgh, PA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Pubmed 29501363
  • National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · UF Health Cancer Center at Orlando Health, 1400 S., Orange Avenue, MP 700, Orlando, FL, 32806, USA. · NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · Yonsei University College of Medicine, Seoul, South Korea. · Genomic Health, Inc, Redwood City, CA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Pubmed 29128898
2017
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; University of Pittsburgh Cancer Institute School of Medicine, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Virginia Commonwealth University, Massey Cancer Center, Richmond, VA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; UF Health Cancer Center at Orland Health, Orlando, FL, USA. · Pubmed 28285537
  • Joanne L. Blum, Lina Asmar, Nicholas J. Robert, Joyce A. O'Shaughnessy, Svetislava J. Vukelja, Devchand Paul, and Stephen E. Jones, US Oncology Research · Lina Asmar, McKesson Specialty Health, The Woodlands · Joanne L. Blum and Joyce A. O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas · Svetislava J. Vukelja, Texas Oncology-Tyler, Tyler, TX · Patrick J. Flynn, Charles E. Geyer Jr, Samuel A. Jacobs, Judith O. Hopkins, Louis Fehrenbacher, Alan P. Lyss, Adam M. Brufsky, Sandra M. Swain, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project/NRG Oncology · Greg Yothers, Jong-Hyeon Jeong, and Linda H. Colangelo, NRG Oncology · Greg Yothers, John-Hyeon Jeong, and Linda H. Colangelo, The University of Pittsburgh · Samuel A. Jacobs, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine · Adam M. Brufsky, Magee-Womens Hospital at University of Pittsburgh Medical Center · Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh · Henry Leonidas Gómez, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network, Philadelphia, PA · Patrick J. Flynn, Metro-Minnesota Community Oncology Research Consortium, Minneapolis, MN · Charles E. Geyer Jr, Massey Cancer Center, Virginia Commonwealth University, Richmond · Nicholas J. Robert, Virginia Cancer Specialists, Fairfax, VA · Judith O. Hopkins, The Southeastern Medical Oncology Center, Goldsboro, NC · Chau T. Dang, The Alliance, Boston, MA · Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York, NY · Henry Leonidas Gómez, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru · Louis Fehrenbacher, Kaiser Permanente Oncology Clinical Trials Northern California, Vallejo, CA · Alan P. Liss, Heartland Cancer Research National Cancer Institute Community Oncology Research Program at Missouri Baptist Cancer Center, St Louis, MO · Devchand Paul, Rocky Mountain Cancer Centers, Denver, CO · Sandra M. Swain, MedStar Washington Hospital Center Washington Cancer Institute, and Georgetown University Medical Center, Washington, DC · and Eleftherios P. Mamounas, UF Cancer Center at Orlando Health, Orlando, FL. · Pubmed 28398846
  • National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania. · Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania3University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania4Kaiser Permanente, Northern California, Vallejo, California. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania5UF Cancer Center at Orlando Health, Orlando, Florida. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania6Washington Cancer Institute, Medstar Washington Hospital Center, Washington, DC7Georgetown University Medical Center, Washington, DC. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania8Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania9Virginia Commonwealth University, Massey Cancer Center, Richmond. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania2Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania10Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · Pubmed 27812689
  • National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Columbia River Oncology Program, Portland, OR. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Medicine, Oncology, University of Pittsburgh Cancer Institute, and Magee-Womens Hospital Womens Cancer Clinic, Pittsburgh, PA. Electronic address: · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Medicine, Oncology, University of Pittsburgh Cancer Institute, and Magee-Womens Hospital Womens Cancer Clinic, Pittsburgh, PA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Centre hospitalier de l'Université de Montreal (CHUM), Montréal, Québec, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Western Oncology Research Consortium, Portland, OR. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Northern Indiana Cancer Research Consortium, Mishawaka, IN. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Southeast Clinical Oncology Research Consortium, Roper St Francis Cancer Care, Charleston, SC. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Michigan Cancer Research Consortium Community, Ann Arbor, MI. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Dayton, Dayton, OH. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Kalamazoo, and the West Michigan Cancer Center, Kalamazoo, MI. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Kaiser Permanente, San Diego, CA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Oncology, UF Cancer Center at Orlando Health, Orlando, FL. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC; Georgetown University Medical Center, Washington, DC. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA. · Pubmed 27693116
  • Affiliations of authors: National Surgical Adjuvant Breast and Bowel Project (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA (EPM, SP, SRK, TBJ, BCL, DLW, NW) · UF Health Cancer Center at Orland Health, Orlando, FL (EPM) · NRG Oncology, Pittsburgh, PA (QL, GT, JHJ, JPC) · University of Pittsburgh, Pittsburgh, PA (QL, GT, JHJ, JPC) · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea (SP) · Genomic Health, Inc., Redwood City, CA (FLB, SMB, FJ, DBC, APS, SS) · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (TBJ, DLW, NW) · University of Pittsburgh Medical Center, Pittsburgh, PA (BCL). · Pubmed 28122895
  • NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · University of Pittsburgh Cancer Institute School of Medicine, Pittsburgh, PA, USA. · Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA. · Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. · San Juan MBCCOP, San Juan, PR, USA. · University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA, USA. · School of Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, CA, USA. · Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA. · CCOP, Colorado Cancer Research Program, Colorado Springs, CO, USA. · CCOP, North-West Medical Specialties, Tacoma, WA, USA. · Kansas City Clinical Oncology Program, Kansas City, MO, USA. · Jewish General Hospital, McGill University, Montréal, QC, Canada. · Genesys Regional Medical Center, Grand Blanc, MI, USA. · Dayton CCOP, Dayton, OH, USA. · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA. · Georgetown University Medical Center, Washington, DC, USA. · UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · Pubmed 27864694
2016
  • NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; University of California, Los Angeles, CA, USA. Electronic address: · NRG Oncology, Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Surgical Oncology, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; The Jewish General Hospital, McGill University, Montréal, QC, Canada. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southwest Oncology Group, San Antonio, TX, USA; Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Alliance for Clinical Trials in Oncology/American College of Surgeons Oncology Group, Chicago, IL, USA; Nashville Breast Center, Nashville, TN, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southwest Oncology Group, San Antonio, TX, USA; Eastern Cooperative Oncology Group/American College of Radiology Imaging Network, Philadelphia, PA, USA; Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Hematology/Oncology, Magee Womens Hospital/University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Dayton Physicians, Dayton, OH, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Missouri Valley Cancer Consortium, Omaha, NE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southeast Clinical Oncology Research Consortium National Cancer Institute Community Oncology Research Program, Winston Salem, NC, USA; Department of Hematology/Oncology, Forsyth Regional Cancer Center, Winston Salem, NC, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Medical Oncology, Kaiser Permanente, Northern California Vallejo, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Medical Oncology Colorado Cancer Research Program, Denver, CO, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Community Clinical Oncology Program, Christiana Care Health Systems, Wilmington, DE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Atlanta Regional Community Clinical Oncology Program, Atlanta, GA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Pubmed 26686960
  • NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Jewish General Hospital, McGill University, Montreal, QC, Canada. Electronic address: · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Surgical Oncology, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; University of California, Los Angeles, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SWOG, San Antonio, TX, USA; Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; ALLIANCE/ACOSOG, Chicago, IL, USA; Nashville Breast Center, Nashville, TN, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SWOG, San Antonio, TX, USA; ECOG/ACRIN, Philadelphia, PA, USA; Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Hematology/Oncology, Magee Womens Hospital/University of Pittsburgh Department of Hematology/Oncology, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Dayton Physicians LLC, Dayton, OH, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Missouri Valley Cancer Consortium, Omaha, NE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SCOR NCORP, Winston Salem, NC, USA; Department of Hematology/Oncology, Forsyth Regional Cancer Center, Winston Salem, NC, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Medical Oncology, Kaiser Permanente Northern California Vallejo, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Medical Oncology Colorado Cancer Research Program, Denver, CO, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; CCOP, Christiana Care Health Systems, Newark, DE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Atlanta Regional Community Clinical Oncology Program, Atlanta, GA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Pubmed 26686957
  • Norman Wolmark, Eleftherios P. Mamounas, and Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project Operations Center · Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital · Gong Tang, University of Pittsburgh · and Gong Tang, NRG Oncology, Pittsburgh, PA · Eleftherios P. Mamounas, UF Health Cancer Center at Orlando Health, Orlando, FL · Frederick L. Baehner, Steven M. Butler, Farid Jamshidian, Amy P. Sing, and Steven Shak, Genomic Health, Redwood City, and Frederick L. Baehner, University of California, San Francisco, San Francisco CA · and Soonmyung Paik, Yonsei University College of Medicine, Seoul, Korea. · Pubmed 27217450
  • NRG Oncology/ National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA (IJ, EHR, EPM, NW) · Department of Surgery University of Texas Health Science Center, San Antonio, TX (IJ) · NRG Oncology Statistics & Data Management Center, and the Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA (HB, JHJ) · NIH/NCI/Division of Cancer Epidemiology and Genetics, Bethesda, MD (WFA) · Markey Cancer Center, University of Kentucky, Lexington, KY (EHR) · UF Cancer Center at Orlando Health, Orlando, FL (EPM) · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (NW). · Pubmed 26518884
2015
  • National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA, USA. Electronic address: · NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Minority-Based CCOP, San Juan, Puerto Rico. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of Pittsburgh Cancer Institute, Magee Womens Hospital, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of California at Irvine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, Orange, CA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Colorado Cancer Research Program, Colorado Springs, CO, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Northwest Medical Specialties, Tacoma, WA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; CCOP, Kansas City, MO, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Jewish General Hospital, McGill University, Montréal, QC, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Genesys Regional Medical Center, Grand Blanc, MI, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; CCOP, Dayton, Dayton, OH, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Pubmed 26272770
  • Katherine L. Pogue-Geile, Nan Song, Patrick G. Gavin, Seong-Rim Kim, Nicole L. Blackmon, Melanie Finnigan, Priya Rastogi, Louis Fehrenbacher, Eleftherios P. Mamounas, Sandra M. Swain, D. Lawrence Wickerham, Charles E. Geyer Jr, Norman Wolmark, and Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project (now part of NRG Oncology) · Jong-Hyeon Jeong and Joseph P. Costantino, NRG Oncology Statistics and Data Management Center · Jong-Hyeon Jeong and Joseph P. Costantino, Graduate School of Public Health, University of Pittsburgh · Priya Rastogi, University of Pittsburgh Cancer Institute · D. Lawrence Wickerham and Norman Wolmark, Allegheny Cancer Center, Allegheny General Hospital, Pittsburgh, PA · Louis Fehrenbacher, Kaiser-Permanente, Northern California, Vallejo, CA · Eleftherios P. Mamounas, UF Health Cancer Center, Orlando Health, Orlando, FL · Sandra M. Swain, Washington Cancer Institute, Medstar Washington Hospital Center, Washington, DC · Charles E. Geyer Jr, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA · and Soonmyung Paik, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea. · Pubmed 25559813
2014
  • US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: · US Food and Drug Administration, Silver Spring, MD, USA. · HELIOS Klinikum, Berlin, Germany. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA. · Institut Bergonié INSERM U916 and Université Bordeaux Segalen, Bordeaux, France. · Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, UK. · San Raffaele Scientific Institute, Milan, Italy. · Fondazione Michelangelo, Milan, Italy. · Medstar Washington Hospital Center, Washington, DC, USA. · EORTC Headquarters, Brussels, Belgium. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · St Gertrauden Hospital, Berlin, Germany. · MD Anderson Cancer Center Orlando, Orlando, FL, USA. · KarolinskaInstitutet and University Hospital, Stockholm, Sweden. · NN Petrov Research Institute of Oncology, St Petersburg, Russia. · University Women's Hospital, Kiel, Germany. · Jules Bordet Institute, Brussels, Belgium. · Frauenklinik des Universitätsklinikums, Erlangen, Germany. · Universitäts Frauenklinik, Rostock, Germany. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Hospital of the Ludwig Maximilian University of Munich, Munich, Germany. · Pubmed 24529560
2013
  • Sandra M. Swain, Gong Tang, Charles E. Geyer Jr, Priya Rastogi, James N. Atkins, Paul P. Donnellan, Louis Fehrenbacher, Catherine A. Azar, André Robidoux, Jonathan A. Polikoff, Adam M. Brufsky, David D. Biggs, Edward A. Levine, John L. Zapas, Louise Provencher, Soonmyung Paik, Joseph P. Costantino, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project (NSABP) · Norman Wolmark, Allegheny General Hospital, Allegheny Health Network · Gong Tang and Joseph P. Costantino, NSABP Biostatistical Center and University of Pittsburgh Graduate School of Public Health · Priya Rastogi, University of Pittsburgh Cancer Institute · Adam M. Brufsky, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA · Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC · Charles E. Geyer Jr, Virginia Commonwealth University, Richmond, VA · James N. Atkins, Southeast Cancer Control Consortium-Community Clinical Oncology Program, Goldsboro · Edward A. Levine, Wake Forest University, Winston-Salem, NC · Paul P. Donnellan, University Hospital, Galway, and the All-Ireland Cooperative Oncology Research Group, Dublin, Ireland · Louis Fehrenbacher, Kaiser Permanente Northern California, Vallejo · Jonathan A. Polikoff, Kaiser Permanente Southern California, San Diego, CA · Catherine A. Azar, Kaiser Permanente, Denver, CO · André Robidoux, Centre hopitalier de l'Université de Montréal (CHUM), Montréal · Louise Provencher, CHU de Québec, Hôpital du Saint-Sacrement, Québec City, QC, Canada · David D. Biggs, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE · John L. Zapas, Medstar Franklin Square Medical Center, Baltimore, MD · Donald W. Northfelt, Mayo Clinic Arizona, Scottsdale, AZ · and Eleftherios P. Mamounas, MD Anderson Cancer Center, Orlando, FL. · Pubmed 23940225
  • Affiliations of authors: National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA (J-HJ, HB, PR, LF, EHR, SMS, EPM, DLW, CEG,Jr, JPC, NW, SP) · Division of Pathology, NSABP (KLP-G, CK, NT, PGG, DF, YT, OLB, AL, S-IK, MLR, MYR, NLB, S-RK, ZDH) · Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA (J-HJ, HB, JPC) · PhenoPath Laboratories, PLLC, Seattle, WA (LCG) · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX (NS) · Department of Pathology, University Medical Center Hamburg-Eppendorf, University Cancer Center, Hamburg, Germany (EB) · Department of Pathology, Catholic University of Korea, Seoul, Republic of South Korea (AL) · University of Pittsburgh Cancer Institute, Pittsburgh, PA (PR) · Department of Oncology, Kaiser Permanente, Northern California, Vallejo, CA (LF) · Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY (EHR) · Department of Medicine, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC (SMS) · Department of Surgery, MD Anderson Cancer Center Orlando, Orlando, FL (EPM) · Department of Medicine, Virginia Commonwealth University, Richmond, VA (CEG, Jr) · Department of Surgery, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (DLW, NW) · Department of Biomedical Science, Severance Biomedical Science Institute, and Department of Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea (SP). · Pubmed 24262440
2015
  • National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA, USA, · Pubmed 25542269
2013
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA. · Pubmed 24202240
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Electronic address: · Pubmed 24095300
Miscellaneous institutions in Pittsburgh
2019
  • NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. · NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. · Centre hospitalier de l'université de Montréal, Montréal, QC, Canada. · Cleveland Clinic, Cleveland, OH, USA. · QuironSalud Group, IOB Institute of Oncology, Madrid, Barcelona, Spain. · Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. · Present address: ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy. · ASST Fatebenefratelli Sacco - PO Fatebenefratelli, Milan, Italy. · Roper St. Francis Healthcare, Charleston, SC, USA. · Azienda Ospedaliera San Gerardo, Monza, Italy. · International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium. · Hospital Universitario, Coruña, Spain. · Fondazione IRCCS Istituto Nazionale di Tumori, Milan, Italy. · Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of South Korea. · Department of Medicine, University of Florida Health, Gainsville, FL, USA. · University of Pittsburgh, Pittsburgh, PA, 15212, USA. · Pubmed 31796073
2018
  • Irene L. Wapnir, Stanford University School of Medicine, Stanford, CA · Karen N. Price and Shari Gelber, Frontier Science and Technology Research Foundation, Richard D. Gelber, Frontier Science and Technology Research Foundation, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, Meredith M. Regan, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA · Stewart J. Anderson, University of Pittsburgh Graduate School of Public Health · Priya Rastogi, University of Pittsburgh Cancer Institute · Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA · André Robidoux, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec · Alexander H.G. Paterson, Tom Baker Cancer Centre, Calgary, Alberta, Canada · Miguel Martín, CIBERONC, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid · José Manuel Baena-Cañada, Hospital Puerta del Mar, Cádiz, Spain · Johan W.R. Nortier, Leids Universitair Medisch Centrum, Leiden, Netherlands · Mothaffar F. Rimawi, Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX · István Láng, National Institute of Oncology, Budapest, Hungary · Beat Thürlimann, Kantonsspital, St. Gallen · Stefan Aebi, Lucerne Cantonal Hospital and University of Bern, Switzerland · Eleftherios P. Mamounas, Orlando Health University of Florida Health Cancer Center, Orlando, FL · Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA · and Alan S. Coates, University of Sydney, Sydney, Australia. · Pubmed 29443653
2017
  • All authors: National Surgical Adjuvant Breast and Bowel Project/NRG Oncology · Reena S. Cecchini, Priya Rastogi, Jong-Hyeon Jeong, and Adam M. Brufsky, University of Pittsburgh · Priya Rastogi and Adam M. Brufsky, Magee-Womens Hospital · Norman Wolmark, Allegheny Health Network Cancer Institute, Pittsburgh, PA · Patricia A. Ganz, University of California at Los Angeles, Los Angeles · Louis Fehrenbacher, Kaiser Permanente, Vallejo · Jonathan Polikoff, Kaiser Permanente, San Marco, CA · Edward H. Romond, University of Kentucky, Lexington, KY · Charles E. Geyer Jr, Virginia Commonwealth University, Richmond, VA · Sandra M. Swain and John L. Zapas, MedStar Washington Hospital Center, Washington, DC · Howard M. Gross, Dayton National Cancer Institute Community Oncology Research Program (NCORP), Dayton, OH · Patrick J. Flynn, Metro-Minnesota Community Clinical Oncology Program (CCOP), Woodbury, MN · Tanya A. Wahl, Fred Hutchinson Cancer Research Center, Seattle, WA · Thomas E. Seay, Atlanta Regional CCOP, Atlanta, GA · James L. Wade III, Heartland NCORP, Decatur, IL · David D. Biggs, Christiana Care Health System, Newark, DE · James N. Atkins, Southeast Clinical Oncology Research Consortium NCORP, Goldsboro, NC · and Eleftherios P. Mamounas, Orlando Health, Orlando, FL. · Pubmed 29072977
  • NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · University of Pittsburgh Cancer Institute School of Medicine, Pittsburgh, PA, USA. · Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA. · Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. · San Juan MBCCOP, San Juan, PR, USA. · University of Pittsburgh/Magee Womens Hospital, Pittsburgh, PA, USA. · School of Medicine, Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, CA, USA. · Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA. · CCOP, Colorado Cancer Research Program, Colorado Springs, CO, USA. · CCOP, North-West Medical Specialties, Tacoma, WA, USA. · Kansas City Clinical Oncology Program, Kansas City, MO, USA. · Jewish General Hospital, McGill University, Montréal, QC, Canada. · Genesys Regional Medical Center, Grand Blanc, MI, USA. · Dayton CCOP, Dayton, OH, USA. · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA. · Georgetown University Medical Center, Washington, DC, USA. · UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · Pubmed 27864694
  • NRG Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · NRG Oncology and University of Florida Health Cancer Center at Orlando Health, Orlando, FL, USA. · NRG Oncology and Centre Hospitalier de l'Universite de Montreal, Montreal, QC, Canada. · GEICAM, Instituto de Investigacion SanitariaGregorio Marañon, Universidad Complutense, Madrid, Spain. · BOOG, Dutch Breast Cancer Trialists' Group, Leids Universitair Medisch Centrum, Leiden, Netherlands. · NRG Oncology and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · NRG Oncology and Tom Baker Cancer Centre, Calgary, Alberta, Canada. · IBCSG and National Institute of Oncology, Budapest, Hungary. · IBCSG, Bern, Switzerland and University of Sydney, Sydney, Australia. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · NRG Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · NRG Oncology and the Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · IBCSG, Luzerner Kantonsspital, Lucerne and University of Berne, Switzerland and Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Pubmed 27663567
2015
  • NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center, 12th Flr., Pittsburgh, PA, 15212, USA. · Pubmed 26126970
University of Pittsburgh
2019
  • NRG Oncology, Pittsburgh, PA, USA; MHP Radiation Oncology Institute, St Joseph Mercy Hospital Campus, Pontiac, MI, USA. Electronic address: · NRG Oncology, Pittsburgh, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology, Pittsburgh, PA, USA; Ohio State University Comprehensive Cancer Center-Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH, USA. · NRG Oncology, Pittsburgh, PA, USA; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA. · NRG Oncology, Pittsburgh, PA, USA; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · NRG Oncology, Pittsburgh, PA, USA; University of Colorado Cancer Center, Aurora, CO, USA. · NRG Oncology, Pittsburgh, PA, USA; Arizona Breast Cancer Specialists, Arizona Center for Cancer Care, Scottsdale, AZ, USA. · NRG Oncology, Pittsburgh, PA, USA; University of California at Los Angeles, Los Angeles, CA, USA. · Carnegie Mellon University, Pittsburgh, PA, USA. · NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, USA. · NRG Oncology, Pittsburgh, PA, USA; Yonsei University College of Medicine, Seoul, Korea. · NRG Oncology, Pittsburgh, PA, USA; MD Anderson Cancer Center, Houston, TX, USA. · Mayo Clinic Florida, Jacksonville, FL, USA. · Southwest Oncology Group Cancer Research Network, Hope Foundation for Cancer Research, Portland, OR, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA. · NRG Oncology, Pittsburgh, PA, USA; Orlando Health, UF Health Cancer Center, Orlando, FL, USA. · NRG Oncology, Pittsburgh, PA, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA. · NRG Oncology, Pittsburgh, PA, USA; Centre Hospitalier Universitaire de Québec-Université Laval, Pavillon Hôtel-Dieu de Québec, Québec City, QC, Canada. · NRG Oncology, Pittsburgh, PA, USA; Community Clinical Oncology Program, William Beaumont Hospital, Sterling Heights, MI, USA. · NRG Oncology, Pittsburgh, PA, USA; Summit Cancer Center, Post Falls, ID, USA. · NRG Oncology, Pittsburgh, PA, USA; Mayo Clinic, Rochester, MN, USA. · NRG Oncology, Pittsburgh, PA, USA; Saint Agnes Hospital, Baltimore, MD, USA; Thomas Jefferson University, Baltimore, MD, USA. · NRG Oncology, Pittsburgh, PA, USA; Winship Cancer Institute of Emory University, Atlanta, GA, USA. · NRG Oncology, Pittsburgh, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. · Pubmed 31813636
  • From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany · the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.) · Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.) · the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.) · the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh · Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.) · Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.) · the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.) · the National Cancer Institute, Mexico City (C.A.-S.) · the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California · Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.) · the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.) · Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai · the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.) · F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.) · and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.). · Pubmed 30516102
  • NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. · NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. · Centre hospitalier de l'université de Montréal, Montréal, QC, Canada. · Cleveland Clinic, Cleveland, OH, USA. · QuironSalud Group, IOB Institute of Oncology, Madrid, Barcelona, Spain. · Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. · Present address: ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy. · ASST Fatebenefratelli Sacco - PO Fatebenefratelli, Milan, Italy. · Roper St. Francis Healthcare, Charleston, SC, USA. · Azienda Ospedaliera San Gerardo, Monza, Italy. · International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium. · Hospital Universitario, Coruña, Spain. · Fondazione IRCCS Istituto Nazionale di Tumori, Milan, Italy. · Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of South Korea. · Department of Medicine, University of Florida Health, Gainsville, FL, USA. · University of Pittsburgh, Pittsburgh, PA, 15212, USA. · Pubmed 31796073
  • National Surgical Adjuvant Breast and Bowel Project (NSABP), Nova Tower 2, 100 Allegheny Square, Pittsburgh, PA, 15212, USA. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP), Nova Tower 2, 100 Allegheny Square, Pittsburgh, PA, 15212, USA. · University of Pittsburgh, 4200 Fifth Ave, Pittsburgh, PA, 15260, USA. · Centre Hospitalier de L'Universite ́ de Montréal, 3840 St Urbain St, Montreal, QC, H2W 1T8, Canada. · Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, Washington, DC, 20057, USA. · Massey Cancer Center, Virginia Commonwealth University, 401 College Street, Box 980037, Richmond, VA, 23298, USA. · Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA, 15213, USA. · Orlando Health UF Health Cancer Center, 1400 S Orange Avenue, Orlando, FL, 32876, USA. · Pubmed 31428908
2012
  • NSABP Biostatistical Center, One Sterling Plaza, Pittsburgh, PA 15213, USA. · Pubmed 23060039
Allegheny General Hospital
2019
  • Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: · McGill University Health Centre, Montreal, QC, Canada. · German Breast Group, Neu-Isenburg, Germany. · University of Ulm, Ulm, Germany. · Texas Oncology-Baylor Sammons Cancer Center/U.S. Oncology, Dallas, TX, USA. · University of California San Francisco, San Francisco, CA, USA. · NSABP Foundation and Allegheny General Hospital, Pittsburgh, PA, USA. · AbbVie, North Chicago, IL, USA. · Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Women and Infants Hospital of Rhode Island, Providence, RI, USA. · Helios Klinikum Berlin-Buch, Berlin, Germany. · Pubmed 31606288
2018
  • National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · UF Health Cancer Center at Orlando Health, 1400 S., Orange Avenue, MP 700, Orlando, FL, 32806, USA. · NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA. · Yonsei University College of Medicine, Seoul, South Korea. · Genomic Health, Inc, Redwood City, CA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Pubmed 29128898
2017
  • Joanne L. Blum, Lina Asmar, Nicholas J. Robert, Joyce A. O'Shaughnessy, Svetislava J. Vukelja, Devchand Paul, and Stephen E. Jones, US Oncology Research · Lina Asmar, McKesson Specialty Health, The Woodlands · Joanne L. Blum and Joyce A. O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas · Svetislava J. Vukelja, Texas Oncology-Tyler, Tyler, TX · Patrick J. Flynn, Charles E. Geyer Jr, Samuel A. Jacobs, Judith O. Hopkins, Louis Fehrenbacher, Alan P. Lyss, Adam M. Brufsky, Sandra M. Swain, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project/NRG Oncology · Greg Yothers, Jong-Hyeon Jeong, and Linda H. Colangelo, NRG Oncology · Greg Yothers, John-Hyeon Jeong, and Linda H. Colangelo, The University of Pittsburgh · Samuel A. Jacobs, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine · Adam M. Brufsky, Magee-Womens Hospital at University of Pittsburgh Medical Center · Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh · Henry Leonidas Gómez, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network, Philadelphia, PA · Patrick J. Flynn, Metro-Minnesota Community Oncology Research Consortium, Minneapolis, MN · Charles E. Geyer Jr, Massey Cancer Center, Virginia Commonwealth University, Richmond · Nicholas J. Robert, Virginia Cancer Specialists, Fairfax, VA · Judith O. Hopkins, The Southeastern Medical Oncology Center, Goldsboro, NC · Chau T. Dang, The Alliance, Boston, MA · Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York, NY · Henry Leonidas Gómez, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru · Louis Fehrenbacher, Kaiser Permanente Oncology Clinical Trials Northern California, Vallejo, CA · Alan P. Liss, Heartland Cancer Research National Cancer Institute Community Oncology Research Program at Missouri Baptist Cancer Center, St Louis, MO · Devchand Paul, Rocky Mountain Cancer Centers, Denver, CO · Sandra M. Swain, MedStar Washington Hospital Center Washington Cancer Institute, and Georgetown University Medical Center, Washington, DC · and Eleftherios P. Mamounas, UF Cancer Center at Orlando Health, Orlando, FL. · Pubmed 28398846
  • National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Columbia River Oncology Program, Portland, OR. · International Drug Development Institute, Louvain-la-Neuve, Belgium. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Medicine, Oncology, University of Pittsburgh Cancer Institute, and Magee-Womens Hospital Womens Cancer Clinic, Pittsburgh, PA. Electronic address: · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Medicine, Oncology, University of Pittsburgh Cancer Institute, and Magee-Womens Hospital Womens Cancer Clinic, Pittsburgh, PA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Centre hospitalier de l'Université de Montreal (CHUM), Montréal, Québec, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Western Oncology Research Consortium, Portland, OR. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Northern Indiana Cancer Research Consortium, Mishawaka, IN. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Southeast Clinical Oncology Research Consortium, Roper St Francis Cancer Care, Charleston, SC. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Michigan Cancer Research Consortium Community, Ann Arbor, MI. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Dayton, Dayton, OH. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Community Clinical Oncology Program (CCOP) Kalamazoo, and the West Michigan Cancer Center, Kalamazoo, MI. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Kaiser Permanente, San Diego, CA. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Department of Oncology, UF Cancer Center at Orlando Health, Orlando, FL. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC; Georgetown University Medical Center, Washington, DC. · National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation, Pittsburgh, PA; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA. · Pubmed 27693116
  • Affiliations of authors: National Surgical Adjuvant Breast and Bowel Project (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA (EPM, SP, SRK, TBJ, BCL, DLW, NW) · UF Health Cancer Center at Orland Health, Orlando, FL (EPM) · NRG Oncology, Pittsburgh, PA (QL, GT, JHJ, JPC) · University of Pittsburgh, Pittsburgh, PA (QL, GT, JHJ, JPC) · Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea (SP) · Genomic Health, Inc., Redwood City, CA (FLB, SMB, FJ, DBC, APS, SS) · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (TBJ, DLW, NW) · University of Pittsburgh Medical Center, Pittsburgh, PA (BCL). · Pubmed 28122895
2016
  • NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; University of California, Los Angeles, CA, USA. Electronic address: · NRG Oncology, Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Surgical Oncology, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; The Jewish General Hospital, McGill University, Montréal, QC, Canada. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southwest Oncology Group, San Antonio, TX, USA; Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Alliance for Clinical Trials in Oncology/American College of Surgeons Oncology Group, Chicago, IL, USA; Nashville Breast Center, Nashville, TN, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southwest Oncology Group, San Antonio, TX, USA; Eastern Cooperative Oncology Group/American College of Radiology Imaging Network, Philadelphia, PA, USA; Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Hematology/Oncology, Magee Womens Hospital/University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Dayton Physicians, Dayton, OH, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Missouri Valley Cancer Consortium, Omaha, NE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Southeast Clinical Oncology Research Consortium National Cancer Institute Community Oncology Research Program, Winston Salem, NC, USA; Department of Hematology/Oncology, Forsyth Regional Cancer Center, Winston Salem, NC, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Medical Oncology, Kaiser Permanente, Northern California Vallejo, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Department of Medical Oncology Colorado Cancer Research Program, Denver, CO, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Community Clinical Oncology Program, Christiana Care Health Systems, Wilmington, DE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; Atlanta Regional Community Clinical Oncology Program, Atlanta, GA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Pubmed 26686960
  • NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Jewish General Hospital, McGill University, Montreal, QC, Canada. Electronic address: · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Surgical Oncology, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; University of California, Los Angeles, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SWOG, San Antonio, TX, USA; Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; ALLIANCE/ACOSOG, Chicago, IL, USA; Nashville Breast Center, Nashville, TN, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SWOG, San Antonio, TX, USA; ECOG/ACRIN, Philadelphia, PA, USA; Department of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Hematology/Oncology, Magee Womens Hospital/University of Pittsburgh Department of Hematology/Oncology, Pittsburgh, PA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Dayton Physicians LLC, Dayton, OH, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Missouri Valley Cancer Consortium, Omaha, NE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; SCOR NCORP, Winston Salem, NC, USA; Department of Hematology/Oncology, Forsyth Regional Cancer Center, Winston Salem, NC, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Medical Oncology, Kaiser Permanente Northern California Vallejo, CA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Department of Medical Oncology Colorado Cancer Research Program, Denver, CO, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; CCOP, Christiana Care Health Systems, Newark, DE, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; Atlanta Regional Community Clinical Oncology Program, Atlanta, GA, USA. · NRG Oncology/National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · Pubmed 26686957
  • NRG Oncology, Pittsburgh, Pennsylvania. University of Pittsburgh, Pittsburgh, Pennsylvania. · NRG Oncology/NSABP, Pittsburgh, Pennsylvania. Washington Cancer Institute, MedStar Washington Hospital Center, Washington, District of Columbia. · NRG Oncology, Pittsburgh, Pennsylvania. University of Pittsburgh, Pittsburgh, Pennsylvania. · NRG Oncology/NSABP, Pittsburgh, Pennsylvania. University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · NRG Oncology/NSABP, Pittsburgh, Pennsylvania. Virginia Commonwealth University (VCU) Massey Cancer Center, Richmond, Virginia. · NRG Oncology/NSABP, Pittsburgh, Pennsylvania. Lucille Parker Markey Cancer Center, University of Kentucky, Lexington, Kentucky. · NRG Oncology/NSABP, Pittsburgh, Pennsylvania. Tom Baker Cancer Centre, Calgary, AB, Canada. · NRG Oncology/NSABP, Pittsburgh, Pennsylvania. Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania. · Pubmed 26545405
  • NRG Oncology/ National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA (IJ, EHR, EPM, NW) · Department of Surgery University of Texas Health Science Center, San Antonio, TX (IJ) · NRG Oncology Statistics & Data Management Center, and the Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA (HB, JHJ) · NIH/NCI/Division of Cancer Epidemiology and Genetics, Bethesda, MD (WFA) · Markey Cancer Center, University of Kentucky, Lexington, KY (EHR) · UF Cancer Center at Orlando Health, Orlando, FL (EPM) · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (NW). · Pubmed 26518884
2015
  • National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA, USA. Electronic address: · NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond, VA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Minority-Based CCOP, San Juan, Puerto Rico. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of Pittsburgh Cancer Institute, Magee Womens Hospital, Pittsburgh, PA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; University of California at Irvine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, Orange, CA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Kaiser Permanente Oncology Clinical Trials, Northern California, Vallejo, CA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Colorado Cancer Research Program, Colorado Springs, CO, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Northwest Medical Specialties, Tacoma, WA, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; CCOP, Kansas City, MO, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Jewish General Hospital, McGill University, Montréal, QC, Canada. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Genesys Regional Medical Center, Grand Blanc, MI, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; CCOP, Dayton, Dayton, OH, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Korea. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. · National Surgical Adjuvant Breast and Bowel Project (NSABP/NRG Oncology), Pittsburgh, PA, USA; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Pubmed 26272770
  • Katherine L. Pogue-Geile, Nan Song, Patrick G. Gavin, Seong-Rim Kim, Nicole L. Blackmon, Melanie Finnigan, Priya Rastogi, Louis Fehrenbacher, Eleftherios P. Mamounas, Sandra M. Swain, D. Lawrence Wickerham, Charles E. Geyer Jr, Norman Wolmark, and Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project (now part of NRG Oncology) · Jong-Hyeon Jeong and Joseph P. Costantino, NRG Oncology Statistics and Data Management Center · Jong-Hyeon Jeong and Joseph P. Costantino, Graduate School of Public Health, University of Pittsburgh · Priya Rastogi, University of Pittsburgh Cancer Institute · D. Lawrence Wickerham and Norman Wolmark, Allegheny Cancer Center, Allegheny General Hospital, Pittsburgh, PA · Louis Fehrenbacher, Kaiser-Permanente, Northern California, Vallejo, CA · Eleftherios P. Mamounas, UF Health Cancer Center, Orlando Health, Orlando, FL · Sandra M. Swain, Washington Cancer Institute, Medstar Washington Hospital Center, Washington, DC · Charles E. Geyer Jr, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA · and Soonmyung Paik, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea. · Pubmed 25559813
2014
  • Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville · Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL · Edward H. Romond, University of Kentucky, Lexington, KY · Vera J. Suman, Mayo Clinic, Rochester, MN · Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh · Nancy E. Davidson, University of Pittsburgh Cancer Institute · Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA · George Sledge, Stanford University School of Medicine, Stanford · Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA · Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA · Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA · Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC · Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA · Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Pubmed 25332249
  • Luzerner Kantonsspital, Lucerne, Switzerland; University of Berne, Berne, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Frontier Science and Technology Research Foundation, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. · National Institute of Oncology, Budapest, Hungary. · Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Leids Universitair Medisch Centrum, Leiden, Netherlands. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Baylor College of Medicine, Houston, TX, USA. · Hospital Puerta Del Mar, Cádiz, Spain. · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St Gallen, Switzerland. · Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. · MD Anderson Cancer Center, Orlando, FL, USA. · Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · International Breast Cancer Study Group, Bern, Switzerland; University of Sydney, Sydney, Australia. · University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA. · Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. · Stanford University School of Medicine, Stanford, CA, USA. · Pubmed 24439313
2013
  • Affiliations of authors: National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA (J-HJ, HB, PR, LF, EHR, SMS, EPM, DLW, CEG,Jr, JPC, NW, SP) · Division of Pathology, NSABP (KLP-G, CK, NT, PGG, DF, YT, OLB, AL, S-IK, MLR, MYR, NLB, S-RK, ZDH) · Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA (J-HJ, HB, JPC) · PhenoPath Laboratories, PLLC, Seattle, WA (LCG) · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX (NS) · Department of Pathology, University Medical Center Hamburg-Eppendorf, University Cancer Center, Hamburg, Germany (EB) · Department of Pathology, Catholic University of Korea, Seoul, Republic of South Korea (AL) · University of Pittsburgh Cancer Institute, Pittsburgh, PA (PR) · Department of Oncology, Kaiser Permanente, Northern California, Vallejo, CA (LF) · Department of Internal Medicine, Markey Cancer Center, University of Kentucky, Lexington, KY (EHR) · Department of Medicine, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC (SMS) · Department of Surgery, MD Anderson Cancer Center Orlando, Orlando, FL (EPM) · Department of Medicine, Virginia Commonwealth University, Richmond, VA (CEG, Jr) · Department of Surgery, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (DLW, NW) · Department of Biomedical Science, Severance Biomedical Science Institute, and Department of Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea (SP). · Pubmed 24262440
Unspecified
2018
  • Department of Oncology. · Department of Health Sciences Research. · Department of Human Oncology, Allegheny Health Network Cancer Institute. · National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP legacy trials are now part of the NRG Oncology portfolio). · Department of Gynecology and Obstetrics, University Hospital, Frankfurt. · Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital, Erlangen, Germany. · RIKEN Center for Integrative Medical Science, Yokohama, Japan. · Department of Medicine, University of Pittsburgh Cancer Institute. · Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. · Yonsei University College of Medicine, Seoul, South Korea. · Department of Surgery, Virginia Commonwealth University, Richmond, Virginia, USA. · Pubmed 29768301
2016
  • Norman Wolmark, Eleftherios P. Mamounas, and Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project Operations Center · Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital · Gong Tang, University of Pittsburgh · and Gong Tang, NRG Oncology, Pittsburgh, PA · Eleftherios P. Mamounas, UF Health Cancer Center at Orlando Health, Orlando, FL · Frederick L. Baehner, Steven M. Butler, Farid Jamshidian, Amy P. Sing, and Steven Shak, Genomic Health, Redwood City, and Frederick L. Baehner, University of California, San Francisco, San Francisco CA · and Soonmyung Paik, Yonsei University College of Medicine, Seoul, Korea. · Pubmed 27217450
2013
  • Sandra M. Swain, Gong Tang, Charles E. Geyer Jr, Priya Rastogi, James N. Atkins, Paul P. Donnellan, Louis Fehrenbacher, Catherine A. Azar, André Robidoux, Jonathan A. Polikoff, Adam M. Brufsky, David D. Biggs, Edward A. Levine, John L. Zapas, Louise Provencher, Soonmyung Paik, Joseph P. Costantino, Eleftherios P. Mamounas, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project (NSABP) · Norman Wolmark, Allegheny General Hospital, Allegheny Health Network · Gong Tang and Joseph P. Costantino, NSABP Biostatistical Center and University of Pittsburgh Graduate School of Public Health · Priya Rastogi, University of Pittsburgh Cancer Institute · Adam M. Brufsky, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA · Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC · Charles E. Geyer Jr, Virginia Commonwealth University, Richmond, VA · James N. Atkins, Southeast Cancer Control Consortium-Community Clinical Oncology Program, Goldsboro · Edward A. Levine, Wake Forest University, Winston-Salem, NC · Paul P. Donnellan, University Hospital, Galway, and the All-Ireland Cooperative Oncology Research Group, Dublin, Ireland · Louis Fehrenbacher, Kaiser Permanente Northern California, Vallejo · Jonathan A. Polikoff, Kaiser Permanente Southern California, San Diego, CA · Catherine A. Azar, Kaiser Permanente, Denver, CO · André Robidoux, Centre hopitalier de l'Université de Montréal (CHUM), Montréal · Louise Provencher, CHU de Québec, Hôpital du Saint-Sacrement, Québec City, QC, Canada · David D. Biggs, Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE · John L. Zapas, Medstar Franklin Square Medical Center, Baltimore, MD · Donald W. Northfelt, Mayo Clinic Arizona, Scottsdale, AZ · and Eleftherios P. Mamounas, MD Anderson Cancer Center, Orlando, FL. · Pubmed 23940225
5 Other Locations Show
Yearly article counts 06485637100
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.